Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease in pyrrole-2-carboxylic acid excretion during lung cancer disease

E Svojtková, Z Deyl, J Andrlíková

    Neoplasma
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Capillary electrophoretic separation of proteins and peptides by ion-pairing with heptanesulfonic acid.

    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2003
    Same author

    Preparative procedures and purity assessment of collagen proteins.

    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2003
    Same author

    Versatile tool for the manipulation of electrophoresis chips.

    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2002
    Same author

    Determination of apparent binding constants of drugs by capillary electrophoresis using beta-cyclodextrin as ligand and three different linear plotting methods.

    Journal of chromatography. A·2001
    Same author

    Hyperoxia and recovery from hypoxia alter collagen in peripheral pulmonary arteries similarly.

    Physiological research·2001
    Same author

    Evaluation of peptide electropherograms by multivariate mathematical-statistical methods. I. Principal component analysis.

    Journal of chromatography. A·2001

    Urine pyrrole-2-carboxylic acid levels significantly drop in early-stage lung cancer patients. This biomarker change is stage-dependent and observed in uranium industry miners.

    Area of Science:

    • Biochemistry
    • Oncology
    • Occupational Health

    Background:

    • Uranium industry miners face chronic radiation exposure, a known risk factor for lung cancer.
    • Biochemical markers in urine may offer insights into early cancer detection and progression.
    • Pyrrole-2-carboxylic acid (PCA) is a metabolite whose urinary levels could potentially indicate disease states.

    Purpose of the Study:

    • To investigate urinary pyrrole-2-carboxylic acid (PCA) levels in lung cancer patients at different stages.
    • To compare PCA excretion in lung cancer patients with healthy individuals from the uranium industry.
    • To assess the influence of nonmalignant lung diseases on PCA levels in cancer patients.

    Main Methods:

    • Quantitative analysis of pyrrole-2-carboxylic acid in urine samples.

    Related Experiment Videos

  • Comparison of PCA levels across different lung cancer stages (I, II, III) using TNM classification.
  • Inclusion of control groups: healthy uranium industry miners and patients with nonmalignant lung diseases (bronchopneumonia, chronic bronchitis).

    • Main Results:

    • A statistically significant decrease in urinary PCA was observed in Stage I lung cancer compared to healthy miners.
    • This PCA decrease was not significant in Stage II lung cancer but reappeared in Stage III.
    • In Stage III lung cancer, the PCA decrease was less pronounced and indistinguishable from levels found in bronchopneumonia or chronic bronchitis.

    Conclusions:

    • Urinary pyrrole-2-carboxylic acid may serve as a potential biomarker for early-stage lung cancer (Stage I) in high-risk populations.
    • The diagnostic utility of PCA as a lung cancer biomarker diminishes in later stages (II and III).
    • Nonmalignant lung conditions can affect PCA excretion, complicating its use as a specific cancer marker in advanced stages.